Evolus Reports Strong Second Quarter 2026 Financial Results; Delivers Third Consecutive Quarter of Positive Adjusted EBITDA and Raises Full-Year 2026 Financial Outlook

Go back to Evolus Reports Strong Second Quarter 2026 Financial Results; Delivers Third Consecutive Quarter of Positive Adjusted EBITDA and Raises Full-Year 2026 Financial Outlook
(NASDAQ: EOLS) Delayed: 7.75 +0.02 (0.26%)
Previous Close $7.73    52 Week High $ 
Open $7.76    52 Week Low $ 
Day High $7.83    P/E N/A 
Day Low $7.67    EPS $ 
Volume 1,002,233